
ZIEXTENZO (Pegfilgrastim-bmez)
ZIEXTENZO is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving…
ZIEXTENZO is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving…
UDENYCA is a leukocyte growth factor indicated to. Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving…
Stimufend is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs…
PEGASYS is an inducer of the innate immune response indicated for the treatment of. Chronic Hepatitis C (CHC) (1.1) Adult Patients: In combination therapy with other hepatitis C virus…
PEGASYS is an inducer of the innate immune response indicated for the treatment of. Chronic Hepatitis C (CHC) (1.1) Adult Patients: In combination therapy with other hepatitis C virus…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.